Quince Therapeutics (QNCX) Market Capitalization (2019 - 2026)

Quince Therapeutics has reported Market Capitalization for 8 years, with the latest figure at $111.6 million in Q2 2026.

• On a quarterly basis, Market Capitalization rose 2421.62% year-over-year to $111.6 million in Q2 2026; TTM through Jun 2026 was $111.6 million, a 2421.62% increase from a year earlier, with the FY2025 full-year figure at $9.3 million, up 126.87% from the prior year.
• Market Capitalization was $111.6 million for Q2 2026 at Quince Therapeutics, up from $462397.2 in the prior quarter.
• The five-year high for Market Capitalization was $111.6 million in Q2 2026, with the low at $462397.2 in Q1 2026.
• Average Market Capitalization over 5 years is $9.4 million, with a median of $2.8 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2026: Market Capitalization slumped 98.24% in 2022, then surged 2421.62% in 2026.
• Over 5 years, Market Capitalization stood at $1.2 million in 2022, then soared by 95.9% to $2.3 million in 2023, then soared by 82.36% to $4.1 million in 2024, then surged by 126.87% to $9.3 million in 2025, then jumped by 1095.17% to $111.6 million in 2026.
• The last three Market Capitalization figures came in at $111.6 million (Q2 2026), $462397.2 (Q1 2026), and $9.3 million (Q4 2025), per Business Quant data.